临床试验在一个盘子里用于心血管医学
Xuekun Wu1,2, Kyle Swanson3,4, Zehra Yildirim1,2
1Stanford Cardiovascular Institute, Stanford University School of Medicine, Stanford, CA 94305, USA.
European heart journal
|September 13, 2024
概括
诱导多能干细胞 (iPSC) 为患者提供了针对心血管药物开发的动物模型的特定替代方案. 这种方法增强了精准医学,并提高了新型心血管治疗的成功率.
科学领域:
- 心血管医学 心血管医学
- 再生医学是一种再生医学.
- 药物发现 药物发现 药物发现
背景情况:
- 心血管疾病 (CVD) 是一个主要的全球健康问题.
- 传统药物开发面临高失败率,原因是动物模型和人类之间的物种间差异.
- 食品和药物管理局现代化法案2.0促进了诸如诱导多能干细胞 (iPSC) 等替代方法.
研究的目的:
- 审查用于心血管研究的iPSC技术的进展.
- 探索iPSCs在疾病建模和心血管疾病药物发现中的应用.
- 提出将iPSC纳入未来临床试验设计的框架.
主要方法:
- 关于iPSC差异化和心血管医学中的应用的当前文献的综述.
- 讨论实施"实验性临床试验"的挑战和机遇.
- 建议一个框架,将iPSC,微生理系统,泛经济学和AI结合起来进行临床试验.
主要成果:
- 人类iPSC为心血管药物测试提供了一个精确的,针对患者的平台.
- 在疾病建模和药物发现方面,iPSC技术取得了重大进展.
- 提出了一个新的框架,以提高心血管药物开发的成功率.
结论:
- iPSC技术代表了心血管精密医学的重大进步.
- 将iPSC与其他新兴技术集成,可以彻底改变心血管医疗保健.
- 拟议的框架旨在提高开发新型心血管治疗的效率和成功.
相关概念视频
Clinical Trials
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
Clinical Trials: Overview
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...


